Font Size

SCREEN

Profile

Direction

Menu Style

 
FINAL website banner 
 
    

OPTIONS X PROGRAMME 

SPECIAL SESSION - LATEST RESEARCH from CHINA

In the changing landscape of global health, China's research capacity has grown substantially over the years. China has also strengthened its global collaboration in influenza research and control. At the same time, many novel influenza subtypes have been identified in birds and humans in China, providing the opportunity to study these viruses and to strengthen clinical and public health response measures against them. In this half-day session, distinguished researchers and policy makers from China will showcase their work on novel influenza in animals and zoonotic infections, as well as novel clinical studies on variously pharmaceuticals, including Chinese medicine. Participants interested to learn about China’s novel research efforts and policies towards influenza are welcome to attend the session.

The session will be conducted in English. Attendance at the session is free-of-charge to all registered participants at OPTIONS X.